Ozkan M - Search Results

1

Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study.

Kaya MG, Ozkan M, Gunebakmaz O, Akkaya H, Kaya EG, Akpek M, Kalay N, Dikilitas M, Yarlioglues M, Karaca H, Berk V, Ardic I, Ergin A, Lam YY. Kaya MG, et al. Among authors: ozkan m. Int J Cardiol. 2013 Sep 1;167(5):2306-10. doi: 10.1016/j.ijcard.2012.06.023. Epub 2012 Jun 22. Int J Cardiol. 2013. PMID: 22727976 Clinical Trial.

2

Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin.

Dogu GG, Ozkan M, Ozturk F, Dikilitas M, Er O, Ozturk A. Dogu GG, et al. Among authors: ozkan m. Med Oncol. 2010 Mar;27(1):34-9. doi: 10.1007/s12032-009-9166-3. Epub 2009 Jan 21. Med Oncol. 2010. PMID: 19156550

3

Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature.

Karaca H, Lale A, Dikilitas M, Ozkan M, Er O. Karaca H, et al. Among authors: ozkan m. Med Oncol. 2010 Sep;27(3):1023-6. doi: 10.1007/s12032-009-9327-4. Epub 2009 Oct 15. Med Oncol. 2010. PMID: 19830602 Review.

4

Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer.

Ozkan M, Akbudak IH, Deniz K, Dikilitas M, Dogu GG, Berk V, Karaca H, Er O, Altinbas M. Ozkan M, et al. Asian Pac J Cancer Prev. 2010;11(1):181-5. Asian Pac J Cancer Prev. 2010. PMID: 20593954 Free article.

5

Refractory generalized seizures as a possible side effect of bevacizumab in a colon cancer patient.

Berk V, Ismailogullari S, Donmez H, Karaca H, Inanc M, Ozkan M. Berk V, et al. Among authors: ozkan m. Med Oncol. 2012 Jun;29(2):1017-9. doi: 10.1007/s12032-011-9921-0. Epub 2011 Apr 2. Med Oncol. 2012. PMID: 21461780

6

Irinotecan as a second-line monotherapy for small cell lung cancer.

Sevinc A, Kalender ME, Altinbas M, Ozkan M, Dikilitas M, Camci C; Anatolian Society of Medical Oncology (ASMO). Sevinc A, et al. Among authors: ozkan m. Asian Pac J Cancer Prev. 2011;12(4):1055-9. Asian Pac J Cancer Prev. 2011. PMID: 21790251 Free article.

7

Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience.

Ozkan M, Berk V, Kaplan MA, Benekli M, Coskun U, Bilici A, Gumus M, Alkis N, Dane F, Ozdemir NY, Colak D, Dikilitas M. Ozkan M, et al. Neoplasma. 2012;59(1):38-42. doi: 10.4149/neo_2012_005. Neoplasma. 2012. PMID: 22103897

8

XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancer.

Berk V, Ozdemir N, Ozkan M, Aksoy S, Turan N, Inal A, Balakan O, Yasar N, Unal OU, Benekli M, Durnali A, Colak D, Sonmez OU. Berk V, et al. Among authors: ozkan m. Hepatogastroenterology. 2012 Nov-Dec;59(120):2635-9. doi: 10.5754/hge12181. Hepatogastroenterology. 2012. PMID: 22534542

9

Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer.

Inanç M, Er O, Karaca H, Berk V, Ozkan M, Saraymen R, Elmalı F. Inanç M, et al. Among authors: ozkan m. Med Oncol. 2012 Dec;29(5):3119-24. doi: 10.1007/s12032-012-0250-8. Epub 2012 May 12. Med Oncol. 2012. PMID: 22580817

10

Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents.

Cetin B, Kaplan MA, Berk V, Ozturk SC, Benekli M, Isıkdogan A, Ozkan M, Coskun U, Buyukberber S. Cetin B, et al. Among authors: ozkan m. Asian Pac J Cancer Prev. 2012;13(3):1059-63. doi: 10.7314/apjcp.2012.13.3.1059. Asian Pac J Cancer Prev. 2012. PMID: 22631638 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,014 results

Search Page

Filters